Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: Latanoprost Free Acid evidence and protocol review
Also known as: Latanoprost acid
Latanoprost Free Acid is the active metabolite of latanoprost, an FDA-approved prostaglandin analog for glaucoma/ocular hypertension. Separately from its approved ophthalmic indication, latanoprost is studied for hair-growth applications: it binds the prostaglandin F2-alpha receptor on hair-follicle dermal papilla cells, increasing the duration of the anagen (growth) phase and resulting in longer, thicker hair shafts - evidence supports its use for both androgenetic alopecia and eyelash/eyebrow hypotrichosis. A registered pilot proof-of-concept clinical trial (ClinicalTrials.gov) is specifically evaluating the therapeutic potential of topical latanoprost acid in hair loss.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Latanoprost free acid is the active metabolite of the approved prodrug latanoprost. XALATAN's 0.005% ophthalmic dose cannot be imported to raw free acid; the hair study was a very small pilot.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.